FRMV promotes cognitive health in organizations and funds research projects aimed at curing Alzheimer's. Memory, judgment, and the experience of people are part of a company's cognitive capital. Without them, it is difficult to sustain talent and competitiveness.
Over 90% of the value of S&P 500 companies corresponds to intangible assets (Ocean Tomo, 2025). Part of that value lies in the people who make decisions, remember processes, and pass on knowledge to the team.
The brain changes associated with Alzheimer's can appear up to 20 years before the first symptoms, when many people are still in the midst of their working lives. Up to 45% of dementia cases could be prevented or delayed by addressing 14 modifiable risk factors (The Lancet Commission, 2024).
FRMV Brain Alliance proposes acting on two fronts: bringing cognitive health closer to teams and funding scientific research to cure Alzheimer's.